Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. SPY
8. TMUS
9. UNP
10. GOOGL

Go back to Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
(NASDAQ: VRAX) Delayed: 3.19 --0 (-0%)
Previous Close $3.19    52 Week High $ 
Open $3.17    52 Week Low $ 
Day High $3.19    P/E N/A 
Day Low $3.11    EPS $ 
Volume 86,303